Astellas Pharma reported 35.8B in EBIT for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Astellas Pharma 4503:JP 35.8B 59.96B
Chugai Pharma 4519:JP 96.71B 32.75B
Daiichi Sankyo 4568:JP 45.77B 71.44B
Eisai 4523:JP 55.41B 61.33B
Kyowa Hakko Kirin 4151:JP 15.11B 148M
M3 2413:JP 15.4B 99M
Otsuka Holdings 4578:JP 59.61B 14.39B
Shionogi 4507:JP 18.79B 3.56B
Sumitomo Dainippon 4506:JP 8.31B 24.65B
Terumo 4543:JP 36.23B 13.12B